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Background:  Contrary to the well studied venous thrombosis, there is limited information regarding management and outcome of peripheral 
arterial thromboembolic events in patients with malignancy or hematologic disorder. Previous published data suggested a very poor outcome with 
a high mortality rate of 83% at one year. Our objective was to evaluate the short term survival rate following an acute peripheral arterial ischemic 
event in our cancer patients.
Methods:  Retrospective chart review of 51 patients (25 men, age 61+ 12 yrs) admitted at the University of Texas MD Anderson Cancer Center with 
acute limb or mesenteric ischemia related to thromboembolic etiology.
Results:  Genitourinary (26%) and gastrointestinal (26%) cancers were the most commonly indentified malignancies. Advanced malignancy was 
present in 27 (53%) patients. Ischemic events occured within 8 weeks of receiving chemotherapy in 19 (37%) patients. Anticoagulation therapy 
(heparin, antiplatelets) was administered to 23 (45%) patients. Twelve (23%) patients received catheter-directed thrombolytic therapy and 20 (39%) 
underwent surgery. Eight (16%) patients had limb amputation. The 30 day and 6 months survival rates were 90% and 72% respectively. The annual 
mortality rate was 37%. There was no difference in outcome (death, amputation) at 6 months and 1 year between treatment groups.
Conclusions:  Patients with underlying malignancy or hematological disorder presenting with acute peripheral arterial ischemic events seem 
to have a higher survival rate at one year than previously reported (17%). With and aggressive therapeutic approach, their 1 year survival rate 
approaches that of non-cancer patients with similar arterial events due to atherosclerosis (75%).
